DAB2IP and neoplasm: To this end, deletion of ovarian carcinoma 2/disabled homolog 2 (DOC-2/DAB2) interacting protein (DAB2IP), is a tumor suppressor in various types of human cancer [5–9] where loss of DAB2IP expression is associated with poor prognosis and increased tumor metastasis [6, 8–11].